Every Mark Has a Reason. Every Reason Has a Treatment.
Diagnosis First, Treatment Second. — Pigmentation is not a single condition. It is a range of distinct conditions that share a surface appearance but originate differently, sit at different depths in the skin, and respond to entirely different treatments. The programme that addresses yours specifically is the only one that will produce lasting results.
Overview
Most patients who arrive at Ministry of Skin with a pigmentation concern have been managing it, in some form, for a long time. They have the vitamin C serums, the niacinamide products, the SPF that they apply — most of the time. Some of it has helped a little. The marks are still there. They return after summer. They return after a breakout. They return after hormonal changes they had no control over. The cycle is familiar and, by the time they arrive here, genuinely frustrating — because they have done the right things, spent the money, been consistent, and the skin still does not look the way they want it to look.
What those experiences share is a fundamental clinical gap: the pigmentation was treated without being diagnosed. A vitamin C serum applied to post-inflammatory hyperpigmentation performs differently from one applied to a solar lentigo. A laser session calibrated for surface pigment deposits will not meaningfully address melasma driven by hormonal melanocyte activity at the dermal-epidermal junction. A depigmentation cream applied to a nevus of Ota — where the pigment sits deep in the dermis — will produce no visible change regardless of the quality of its formulation. These are not failures of effort. They are failures of specificity. The treatment was not wrong because it was ineffective in general — it was wrong because it was not matched to this particular pigmentation, in this particular patient, at this particular depth.
At Ministry of Skin, every pigmentation programme begins with a clinical diagnostic assessment — including dermoscopy and Wood's lamp examination to determine the depth and distribution of the pigmentation, combined with a thorough clinical history to identify the driving factors. Only once the diagnosis is established does treatment begin. The approach we recommend will be the one matched to your specific presentation — not the most popular option, not the most heavily marketed device, but the most clinically appropriate programme for the pigmentation you actually have.
What Pigmentation Treatment Actually Does
Melanin — the pigment produced by melanocytes in the skin — is a protective molecule, synthesised in response to UV exposure and inflammatory signals as a form of cellular defence. In healthy, well-regulated skin, melanin production is balanced and evenly distributed. In compromised skin — whether compromised by hormonal exposure, UV damage, inflammatory injury, or genetic predisposition — the regulation of melanin synthesis and distribution breaks down, producing the deposits that patients present with.
Effective pigmentation treatment must address this breakdown at the level where it originates. For superficial epidermal pigmentation — freckles, surface lentigines, mild PIH — exfoliating and targeted topical treatments can reach the pigment and interrupt its production effectively. For deeper deposits sitting at or below the dermal-epidermal junction — melasma, deeper PIH, nevus of Ota — topical treatments alone are insufficient, because the pigment sits beyond the depth they can reach, and the melanocyte overactivity driving it is responding to biological signals that a cream cannot neutralise. For these presentations, clinical intervention at the appropriate depth — laser energy calibrated for the specific pigment depth, or a professional depigmentation system that inhibits melanogenesis at multiple points simultaneously — is not optional. It is what makes the difference between improvement and frustration.
Treatment By Pigmentation Type
What We Treat and How
Melasma is a chronic hormonal pigmentation condition characterised by symmetrical patches of brown or grey-brown discolouration — most commonly affecting the cheeks, upper lip, forehead, and chin — driven by oestrogen-sensitive melanocyte overactivity in combination with UV exposure. It is one of the most challenging pigmentation conditions to treat because it is prone to recurrence, responds inconsistently to standard laser treatment, and requires a sustained approach rather than a finite course. At Ministry of Skin, melasma is managed through the Cosmelan depigmentation system — developed by mesoestetic, for which Dr. Dhavala holds a Key Opinion Leader designation — as the primary in-clinic treatment, combined with Pico laser using the Fotona Starwalker in Pulsed Wave mode through Sylfirm X where the vascular component at the basement membrane zone is contributing to melanocyte dysregulation, a precision-formulated topical maintenance programme, and daily broad-spectrum SPF 50+ as the non-negotiable foundation of every melasma programme. Cosmelan inhibits melanin synthesis at multiple points in the melanogenesis pathway simultaneously — producing a more comprehensive and more sustained depigmentation than single-ingredient approaches — and its combination with targeted laser and structured maintenance produces the most consistent long-term improvement in melasma we achieve. The goal of melasma management is not a single curative course. It is achieving and sustaining the best possible clarity through a programme that addresses both the existing pigment and the ongoing hormonal and UV drivers that produce it.
Post-Inflammatory Hyperpigmentation is the flat discolouration that follows inflammation — from acne, eczema, injury, procedures, or any other source of skin trauma — produced by the reactive overproduction of melanin at the site of the inflammatory episode. It is extremely common and, for many patients, more distressing than the original condition that caused it — because it is visible long after the inflammation itself has resolved, and because the timeline for natural clearance can be months to years without intervention. At Ministry of Skin, PIH is treated through Pico laser sessions targeting the melanin deposits specifically, supported by chemical peels — glycolic, salicylic, or dermamelan — to accelerate surface turnover and reduce the epidermal melanin load, and a topical programme including tranexamic acid, kojic acid, and niacinamide to inhibit new melanin formation during the treatment period. PIH generally responds more predictably to treatment than melasma — because it is reactive rather than hormonally driven — and most patients with recent PIH achieve significant improvement within a structured 3–4 month programme, with older marks requiring more sessions but nonetheless responding well to the correct approach.
Sun Damage and Solar Lentigines — the discrete, well-defined spots produced by cumulative UV exposure — are among the most straightforward presentations of pigmentation to treat effectively. They are predominantly epidermal, their melanin deposits are accessible to laser targeting, and they respond rapidly and cleanly to the appropriate laser wavelength and pulse duration. At Ministry of Skin, solar lentigines are treated with Pico laser using the Fotona Starwalker or the Q Laze Q-Switch system — the choice between them guided by the depth and character of the individual lesion — producing significant lightening or complete clearance in 1–3 sessions for most presentations. Sun damage management at Ministry of Skin also incorporates topical maintenance and, critically, a structured conversation about ongoing sun protection — because solar lentigines treated without addressing the UV exposure that produced them will recur, and the clinical value of a treatment course that precedes continued unprotected exposure is limited.
Diffuse Skin Darkening — a generalised reduction in the overall evenness and luminosity of the skin without a clearly defined pattern of lesions — is produced by a combination of factors including cumulative UV exposure, hormonal influences, environmental pollution, oxidative stress, and in some cases internal health factors that affect melanin regulation systemically. At Ministry of Skin, diffuse skin darkening is addressed through a combination of professional depigmentation peels, Glutathione IV Infusion for systemic melanin inhibition and antioxidant loading, targeted topical therapy, and laser toning with the Q Laze or Fotona Starwalker for overall melanin reduction and skin brightening. The Glutathione IV programme is particularly relevant for this presentation — delivering therapeutic concentrations of the body's most powerful natural antioxidant intravenously, where it inhibits tyrosinase activity systemically and shifts melanin production toward the lighter phaeomelanin type, producing a progressive and even improvement in overall skin luminosity that topical applications cannot replicate.
Nevus of Ota is a congenital or acquired blue-grey pigmentation distributed along the first and second branches of the trigeminal nerve — typically affecting one side of the face including the periorbital area, cheek, temple, and occasionally the sclera of the eye. The pigment sits deep in the dermis — well below the reach of topical treatments and superficial laser modalities — and requires the specific penetration depth and wavelength of the Q-Switch Nd:YAG or Pico laser to reach the dermal melanocytes responsible for the discolouration. At Ministry of Skin, Nevus of Ota is treated with a carefully planned programme of Q-Switch or Pico laser sessions using the Q Laze or Fotona Starwalker — calibrated specifically for dermal pigment targeting — producing progressive lightening over a course of sessions. It is a condition that requires realistic expectations and patience: the pigment is deep, and meaningful improvement accumulates over multiple sessions rather than appearing rapidly. Significant improvement is achievable for most patients; complete clearance in all cases is not guaranteed — and this is discussed honestly at every initial consultation.
Results, Realistic Expectations, and the Role of Sun Protection
Pigmentation improvement is almost always progressive rather than immediate — developing over weeks to months as the melanin deposits are cleared, melanocyte overactivity is reduced, and the skin's natural renewal cycle brings the treated tissue progressively to the surface. For recent PIH and surface solar lentigines, meaningful improvement is often visible within 4–8 weeks of commencing treatment. For melasma, the most significant improvement from the Cosmelan programme typically becomes apparent at 4–8 weeks from the in-clinic application, with continued improvement over 3–6 months of home maintenance. For nevus of Ota, progressive lightening develops over a series of sessions spaced 6–8 weeks apart, with the full improvement of a treatment course assessed at a minimum of 3 months following the final session.
There is, however, one factor that determines more than any other whether pigmentation results last — and it is not the treatment used. It is sun protection. UV exposure is the primary driver of melanocyte activation across every form of pigmentation, and without daily broad-spectrum SPF 50+ application — not occasionally, not in summer, but every morning, every day — the investment of a pigmentation programme is systematically undermined. Pigmentation that has been cleared with laser or peels will return if the melanocytes responsible for producing it continue to receive the UV signal that activates them. At Ministry of Skin, sun protection is discussed at every consultation and every session — not as an afterthought, but as the clinical foundation on which every other element of a pigmentation programme depends.
Clients
Testimonials
Frequently Asked Questions
Why does my pigmentation keep coming back after treatment?
Pigmentation recurs when the underlying driver of melanocyte overactivity continues after the existing melanin deposits have been cleared. For melasma, the hormonal sensitivity of the melanocytes is not resolved by treatment — it is managed. For PIH, any new inflammatory episode will trigger a new pigmentation response. For solar lentigines, continued UV exposure will produce new lesions. This is why the treatment of pigmentation at Ministry of Skin always involves both clearing existing pigment and managing the ongoing drivers through maintenance topical therapy, photoprotection, and where relevant, lifestyle and hormonal factors. Clearing pigmentation without addressing what produces it is a treatment that works — temporarily.
What is the difference between the Pico laser and Q-Switch laser for pigmentation?
Both the Pico laser — using the Fotona Starwalker — and the Q-Switch laser — using the Q Laze — target melanin through selective photothermolysis, but they do so at different pulse durations and through different mechanisms. Pico laser delivers energy in picoseconds — one trillionth of a second — producing a photoacoustic shockwave that shatters melanin particles mechanically with minimal thermal damage to surrounding tissue. Q-Switch laser delivers energy in nanoseconds, producing photothermal fragmentation of melanin particles. Pico laser is generally more effective for stubborn and deeper pigmentation, including treatment-resistant melasma and dermal pigment deposits, and produces less thermal collateral effect. Q-Switch is highly effective for surface pigmentation, lentigines, and general skin brightening. The choice between them — and the use of both across a programme — is guided by the type and depth of the pigmentation being addressed, which your dermatologist determines at your assessment.
Is melasma curable?
Melasma is a manageable condition rather than a curable one. The hormonal sensitivity of the melanocytes that drives it does not resolve with treatment — which means that the pigmentation can be significantly cleared and substantially controlled, but requires ongoing management to remain so. The goal of melasma treatment at Ministry of Skin is to achieve the best possible clarity and maintain it through a structured maintenance programme — not to promise a single course that resolves the condition permanently. Many patients manage their melasma very successfully long-term through consistent maintenance therapy, excellent photoprotection, and periodic in-clinic treatments.
How many sessions will I need?
Session numbers vary significantly by pigmentation type and severity. Surface solar lentigines may clear in 1–3 Pico or Q-Switch laser sessions. Recent PIH typically requires 3–5 sessions over 3–4 months alongside topical therapy. Melasma requires the full Cosmelan protocol plus a maintenance programme, with laser sessions added as needed. Nevus of Ota typically requires 6–10 or more sessions over 12–18 months for significant improvement. Your dermatologist will provide a specific estimate and programme plan following your initial assessment — and will review progress and adjust the programme at regular intervals throughout.
Can I treat pigmentation at home between clinic sessions?
Yes — and the home programme is an essential component of every pigmentation treatment at Ministry of Skin, not an optional add-on. Between clinic sessions, your dermatologist will prescribe a specific topical regimen — typically including tranexamic acid, kojic acid, azelaic acid, niacinamide, or Vitamin C derivatives depending on your pigmentation type — to inhibit ongoing melanin production, support the clearance being achieved in clinic, and reduce the risk of recurrence. The home programme extends the clinical effect of each session into every day between them, and the patients who follow it consistently achieve both faster and more sustained improvement than those who rely on clinic sessions alone.
